feed,title,long_url,short_url
MedRxiv,Lenzilumab outcomes according to race of covid-19 participants in the live-air phase 3 trial,https://medrxiv.org/cgi/content/short/2022.08.18.22278867v1?rss=1,https://bit.ly/3QF2vG1
